Evidence map›Paper›PMID 30464585›Full record

ArticleJournal of pain research2018

Epidural dexmedetomidine infusion for perioperative analgesia in patients undergoing abdominal cancer surgery: randomized trial.

Diab Fuad Hetta, Khaled Mohamed Fares, Abualauon Mohamed Abedalmohsen, Amani Hassan Abdel-Wahab, Ghada Mohammed Abo Elfadl, Wesam Nashat Ali

3 registry-linked trialsOpen access · goldAbstract read
In one paragraph

Article in Journal of pain research, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 3 registered trials, which are not on this map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05323214 phase4unknown statusnot on this mapstarted 2021, after this paper: background citation

Comparative Study Between Dexmedetomidine and Fentanyl as Adjuvants to Bupivacaine for Post-operative Epidural Analgesia in Abdominal Surgeries

TypeinterventionalSponsorAin Shams UniversityRan2021 to 2022Enrolled75ConditionsEpidural AnalgesiaArmsControl Analgesic regimen, Fentanyl Analgesic regimen, Dexmedetomidine Analgesic regimen
NCT05698407 phase4completednot on this mapstarted 2023, after this paper: background citation

Effect of Dexmedetomidine Plus Ropivacaine Versus Sufentanil Plus Ropivacaine for Epidural Labor Analgesia on Neonatal Outcomes: a Pilot Randomized Trial

TypeinterventionalSponsorPeking University First HospitalRan2023 to 2023Enrolled200ConditionsPregnancy RelatedArmsDexmedetomidine, Sufentanil
NCT07292324 phase4completednot on this mapstarted 2025, after this paper: background citation

Effectiveness of Continuous Epidural With Dexmedetomidine Adjuvant Compared to Without Adjuvant in Gynecologic Laparotomy

TypeinterventionalSponsorUdayana UniversityRan2025 to 2026Enrolled62ConditionsPost Operative Pain, Acute, Chronic Post Surgical Pain, Gynecologic DiseaseArmsDexmedetomidine & Bupivacaine., Bupivacain
3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 21 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Diab Fuad HettaAnesthesia and Pain Management, South Egypt Cancer Institute, diabhetta25@gmail.com.
Khaled Mohamed FaresAnesthesia and Pain Management, South Egypt Cancer Institute, diabhetta25@gmail.com.
Abualauon Mohamed AbedalmohsenAnesthesia and Intensive Care, Faculty of Medicine, Assuit University, Assuit, Egypt.
Amani Hassan Abdel-WahabAnesthesia and Intensive Care, Faculty of Medicine, Assuit University, Assuit, Egypt.
Ghada Mohammed Abo ElfadlAnesthesia and Intensive Care, Faculty of Medicine, Assuit University, Assuit, Egypt.
Wesam Nashat AliAnesthesia and Intensive Care, Faculty of Medicine, Assuit University, Assuit, Egypt.
Assiut University · EGChildren Cancer Hospital · EG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo assess the postoperative analgesic efficacy of epidural dexmedetomidine added to bupivacaine infusion for patients undergoing major abdominal cancer surgery.

methodsPatients scheduled for major upper abdominal cancer surgery were allocated to group bupivacaine (n =32), in which patients received epidural bupivacaine infusion (6 mL/h bupivacaine 0.1%) for 48 hours postoperatively, or group bupivacaine + dexmedetomidine (n=32), in which patients received epidural dexmedetomidine added to bupivacaine infusion (6 mL/h of bupivacaine 0.1% + dexmedetomidine, 0.5 µg/mL) for 48 hours postoperatively. The cumulative morphine consumption, the time to first analgesic request, and the VAS pain score were evaluated.

resultsThe cumulative morphine consumption was significantly reduced in group bupivacaine + dexmedetomidine compared with group bupivacaine: mean ± SD of 10.40±5.16 mg vs 23.23±8.37 mg with an estimated difference (95% CI) of -12.83 (-16.43, -9.24), (

conclusionEpidural infusion of dexmedetomidine added to bupivacaine for patients undergoing major abdominal cancer surgery significantly reduced morphine consumption, delayed time to first analgesic supplementation, and decreased pain intensity during the first 48 hours postoperatively without harmful derangement on hemodynamics.

Indexed as

dexmedetomidineepiduralpostoperative pain

Identifiers

PMID30464585
PMCPMC6214321
OpenAlexW2899399281

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.